Impact of Medication Reconciliation by a Dialysis Pharmacist
- PMID: 36128498
- PMCID: PMC9438412
- DOI: 10.34067/KID.0007182021
Impact of Medication Reconciliation by a Dialysis Pharmacist
Abstract
Integrating a pharmacist into a hemodialysis unit significantly reduced medication discrepancies and medication-related problems over time.Medication reconciliation for the Centers for Medicare and Medicaid Services End-Stage Renal Disease Quality Incentive Program can be optimally performed by a dialysis pharmacist.
Keywords: dialysis; medication discrepancy; medication error; medication reconciliation; medication related problems; medication safety; pharmacist; pharmacy.
Copyright © 2022 by the American Society of Nephrology.
Conflict of interest statement
L. Awdishu reports honoraria from the American Society of Nephrology and the American Board of Internal Medicine and is a member of the American Board of Internal Medicine Nephrology Board. S. Rafie reports consultancy agreements with GenBioPro and TherapeuticsMD; is a scientific advisor for or member of Afaxys; and has participated in a speakers’ bureau for TherapeuticsMD. All remaining authors have nothing to disclose.
Figures


Similar articles
-
Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.Am J Kidney Dis. 2020 Dec;76(6):868-876. doi: 10.1053/j.ajkd.2020.07.021. Epub 2020 Sep 10. Am J Kidney Dis. 2020. PMID: 32920154 Free PMC article. Review.
-
The impact of pharmacist-led medication reconciliation during admission at tertiary care hospital.Int J Clin Pharm. 2018 Feb;40(1):196-201. doi: 10.1007/s11096-017-0568-6. Epub 2017 Dec 16. Int J Clin Pharm. 2018. PMID: 29248986
-
Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain.Int J Clin Pharm. 2013 Dec;35(6):1083-90. doi: 10.1007/s11096-013-9824-6. Epub 2013 Jul 24. Int J Clin Pharm. 2013. PMID: 23881347
-
Effectiveness and feasibility of pharmacist-led admission medication reconciliation for geriatric patients.J Pharm Pract. 2012 Apr;25(2):136-41. doi: 10.1177/0897190011422605. Epub 2011 Nov 2. J Pharm Pract. 2012. PMID: 22048929 Clinical Trial.
-
Effect of pharmacy-led medication reconciliation in emergency departments: A systematic review and meta-analysis.J Clin Pharm Ther. 2019 Dec;44(6):932-945. doi: 10.1111/jcpt.13019. Epub 2019 Aug 22. J Clin Pharm Ther. 2019. PMID: 31436877
Cited by
-
Effect of a Population Health Management Intervention on Medication Therapy Problems in People With Chronic Kidney Disease: Post Hoc Analysis of the K-CHAMP Cluster-Randomized Trial.Kidney Med. 2025 Mar 18;7(5):100995. doi: 10.1016/j.xkme.2025.100995. eCollection 2025 May. Kidney Med. 2025. PMID: 40330910 Free PMC article.
-
Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.Nephrol Dial Transplant. 2025 Apr 28;40(5):884-907. doi: 10.1093/ndt/gfae221. Nephrol Dial Transplant. 2025. PMID: 39384574 Free PMC article.
-
KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: A primer on what pharmacists need to know.Am J Health Syst Pharm. 2025 Jun 11;82(12):660-671. doi: 10.1093/ajhp/zxaf044. Am J Health Syst Pharm. 2025. PMID: 40197825 Free PMC article. Review.
-
Implementation of medication reconciliation in outpatient cancer care.BMJ Open Qual. 2023 May;12(2):e002211. doi: 10.1136/bmjoq-2022-002211. BMJ Open Qual. 2023. PMID: 37247944 Free PMC article.
-
Prevalence of potentially inappropriately prescribed medications among older adults receiving peritoneal dialysis.Pharmacotherapy. 2025 Apr;45(4):203-210. doi: 10.1002/phar.70008. Epub 2025 Mar 4. Pharmacotherapy. 2025. PMID: 40035429 Free PMC article.
References
-
- Manley HJ, Garvin CG, Drayer DK, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS: Medication prescribing patterns in ambulatory haemodialysis patients: Comparisons of USRDS to a large not-for-profit dialysis provider. Nephrol Dial Transplant 19: 1842–1848, 2004. 10.1093/ndt/gfh280 - DOI - PubMed
-
- Centers for Medicare & Medicaid Services (CMS), HHS : Medicare and Medicaid programs; conditions for coverage for end-stage renal disease facilities. Final rule. Fed Regist 73: 20369–20484, 2008 - PubMed